Perimeter Medical Imaging AI Set to Engage Investors in Upcoming Webcast on February 6th
On February 6, 2025, Perimeter Medical Imaging AI, Inc. will hold an important investor webinar at 2 PM ET, hosted by Bristol Investor Relations. This event promises to offer significant insights into the company's operations and strategies, as key executives including CEO Adrian Mendes, CIO Andrew Berkeley, and CFO Sara Brien will present crucial information pertaining to their innovative medical technology.
Perimeter Medical is focused on improving cancer surgery through advanced imaging technology. Their flagship product, the FDA-cleared Perimeter S-Series OCT system, enables real-time, cross-sectional visualization of excised tissues at the cellular level. This technology is revolutionary for surgeons, providing a tool to ensure that cancerous tissues have been fully removed during surgeries. The company is built on a foundation of addressing significant unmet medical needs in cancer care, driven by scientific innovation and patient-centered solutions.
During the webinar, the executives will cover various key areas of the business, aligning their current goals with the overall vision of improving surgical outcomes for cancer patients. Investors are encouraged to prepare questions as there will be an interactive Q&A segment following the presentation, providing a chance to engage with the leadership team.
To participate in the live event, interested individuals must pre-register through the provided link. An archived version of the webcast will be made available on the company's website post-event, allowing those who could not attend live to catch up on the insights shared.
Headquartered in Toronto and Dallas, Perimeter Medical is a pioneer in medical imaging, especially in oncology. Their next-generation product, the investigational Perimeter B-Series OCT system with ImgAssist AI, is currently under clinical evaluations, which have received substantial backing from the Cancer Prevention and Research Institute of Texas. This indicates a strong commitment not only to innovation but to advancing clinical research, which ultimately reinforces the foundation upon which the company is built.
Perimeter's impressive stock ticker, 'PINK,' represents a tribute to the campaigns surrounding Breast Cancer Awareness Month, strengthening its brand's focus on providing impactful solutions to improve patient care.
Investors should be aware that, while Perimeter continues to innovate, the B-Series OCT is still under investigational use and is not yet available for sale. Comprehensive insights into the latest advancements and safety evaluations for their technologies will also be discussed during the webinar.
The medical technology landscape is evolving rapidly, and the demand for innovative solutions is at an all-time high. In this setting, Perimeter Medical Imaging AI positions itself as a key contributor with its cutting-edge tools aimed at enhancing surgical precision for cancer care. As the company prepares to engage with investors, those interested in the nuances of healthcare technology and the financial implications behind these advancements should not miss this opportunity to learn more about Perimeter’s mission and vision for the future of cancer surgery.
Perimeter Medical is focused on improving cancer surgery through advanced imaging technology. Their flagship product, the FDA-cleared Perimeter S-Series OCT system, enables real-time, cross-sectional visualization of excised tissues at the cellular level. This technology is revolutionary for surgeons, providing a tool to ensure that cancerous tissues have been fully removed during surgeries. The company is built on a foundation of addressing significant unmet medical needs in cancer care, driven by scientific innovation and patient-centered solutions.
During the webinar, the executives will cover various key areas of the business, aligning their current goals with the overall vision of improving surgical outcomes for cancer patients. Investors are encouraged to prepare questions as there will be an interactive Q&A segment following the presentation, providing a chance to engage with the leadership team.
To participate in the live event, interested individuals must pre-register through the provided link. An archived version of the webcast will be made available on the company's website post-event, allowing those who could not attend live to catch up on the insights shared.
Headquartered in Toronto and Dallas, Perimeter Medical is a pioneer in medical imaging, especially in oncology. Their next-generation product, the investigational Perimeter B-Series OCT system with ImgAssist AI, is currently under clinical evaluations, which have received substantial backing from the Cancer Prevention and Research Institute of Texas. This indicates a strong commitment not only to innovation but to advancing clinical research, which ultimately reinforces the foundation upon which the company is built.
Perimeter's impressive stock ticker, 'PINK,' represents a tribute to the campaigns surrounding Breast Cancer Awareness Month, strengthening its brand's focus on providing impactful solutions to improve patient care.
Investors should be aware that, while Perimeter continues to innovate, the B-Series OCT is still under investigational use and is not yet available for sale. Comprehensive insights into the latest advancements and safety evaluations for their technologies will also be discussed during the webinar.
The medical technology landscape is evolving rapidly, and the demand for innovative solutions is at an all-time high. In this setting, Perimeter Medical Imaging AI positions itself as a key contributor with its cutting-edge tools aimed at enhancing surgical precision for cancer care. As the company prepares to engage with investors, those interested in the nuances of healthcare technology and the financial implications behind these advancements should not miss this opportunity to learn more about Perimeter’s mission and vision for the future of cancer surgery.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.